The company have set TP of GBX 925.00 on Bodycote PLC (LON:BOY) shares. This is 5.11% from the last price. In an analyst note revealed to investors on Wednesday morning, Numis reaffirmed their “Hold” rating on shares of BOY.
Among 2 analysts covering Verona Pharma PLC (LON:VRP), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Verona Pharma PLC had 22 analyst reports since September 18, 2015 according to SRatingsIntel. The stock of Verona Pharma plc (LON:VRP) has “Buy” rating given on Monday, November 27 by N+1 Singer. The firm has “Corporate” rating by N+1 Singer given on Wednesday, January 18. The firm earned “Corporate” rating on Wednesday, November 11 by N+1 Singer. N+1 Singer maintained the stock with “Corporate” rating in Monday, January 11 report. The stock of Verona Pharma plc (LON:VRP) earned “Corporate” rating by N+1 Singer on Thursday, October 8. The stock of Verona Pharma plc (LON:VRP) earned “Buy” rating by N+1 Singer on Tuesday, November 7. The firm earned “Corporate” rating on Wednesday, March 22 by N+1 Singer. N+1 Singer maintained the shares of VRP in report on Friday, September 18 with “Corporate” rating. The rating was maintained by N+1 Singer with “Corporate” on Wednesday, October 14. The firm earned “Buy” rating on Wednesday, November 8 by Jefferies. See Verona Pharma plc (LON:VRP) latest ratings:
27/11/2017 Broker: N+1 Singer Rating: Buy New Target: GBX 327.00 Maintain
08/11/2017 Broker: Jefferies Rating: Buy Old Target: GBX 250.00 New Target: GBX 250.00 Maintain
07/11/2017 Broker: N+1 Singer Rating: Buy Maintain
The stock increased 0.74% or GBX 6.5 during the last trading session, reaching GBX 886.5. About 45,405 shares traded. Bodycote plc (LON:BOY) has 0.00% since February 14, 2017 and is . It has underperformed by 16.70% the S&P500.
Bodycote plc provides thermal processing services worldwide. The company has market cap of 1.69 billion GBP. The firm operates in two business areas, Aerospace, Defence & Energy; and Automotive & General Industrial. It has a 21.83 P/E ratio. It offers heat treatment services, including altering the microstructure of metals and alloys, such as steel and aluminum to impart properties comprising surface hardness, temperature resistance, ductility, and strength; metal joining services consisting of electron beam welding, and vacuum and honeycomb brazing; and Hot isostatic pressing services, including HIP product fabrication, isostatic pressing, and HIP supporting services.
Among 22 analysts covering Bodycote PLC (LON:BOY), 14 have Buy rating, 2 Sell and 6 Hold. Therefore 64% are positive. Bodycote PLC has GBX 1105 highest and GBX 500 lowest target. GBX 813’s average target is -8.29% below currents GBX 886.5 stock price. Bodycote PLC had 157 analyst reports since July 30, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Friday, November 20. The rating was maintained by Canaccord Genuity with “Buy” on Monday, February 8. The stock has “Sector Perform” rating by RBC Capital Markets on Monday, November 30. The stock has “Hold” rating by Numis Securities on Monday, January 15. As per Monday, November 21, the company rating was maintained by Deutsche Bank. The stock of Bodycote plc (LON:BOY) earned “Hold” rating by HSBC on Thursday, April 6. The firm earned “Underweight” rating on Monday, September 28 by JP Morgan. Liberum Capital maintained Bodycote plc (LON:BOY) rating on Thursday, July 30. Liberum Capital has “Buy” rating and GBX 800 target. JP Morgan maintained it with “Underweight” rating and GBX 520 target in Wednesday, September 30 report. As per Monday, November 21, the company rating was maintained by Beaufort Securities.